Adhesion Barrier Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

Adhesion Barrier Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

The adhesion Barrier market is expected to register a CAGR of 7.9% over the forecast period, 2022-2027.

The pandemic had ramifications for ways of working on various surgical procedures. There are strict guidelines specific to each specialty that must be implemented and followed for surgeons to continue to provide safe and effective care to their patients during the COVID-19 pandemic. For instance, according to the World Economic Forum, in 2020, 38% of global cancer surgery has been postponed or cancelled. According to a research article published in the International Journal of Surgery in July 2020, titled 'Impact of the Coronavirus (COVID-19) Pandemic on Surgical Practice - Part 2 (Surgical Prioritisation)' all surgical specialties have had to limit their surgical practices and prioritize the necessary surgeries. The selection of patients for urgent surgery during the pandemic is vitally essential to ensure that patients have post-operative reserves to combat any possibility of being infected with COVID-19. Thus, the reduction in the number of surgical procedures during the COVID-19 pandemic is expected to negatively impact the market's growth. However, during the post-pandemic period, the postponed surgeries resumed, which boosted the market's growth.

Certain factors that are driving the market growth include an increase in the volume of surgeries and sports-related injuries and rising awareness about the medical implications of adhesions.

According to the article 'Trauma of Major Surgery' published in the National Center for Biotechnology Information (NCBI) in July 2020, globally, a staggering 310 million major surgeries are performed each year. Moreover, according to the article named 'Incidence and Cumulative Risk of Major Surgery in Older Persons in United States' published in July 2021, in United States Nearly nine major surgeries were performed annually for every 100 older persons, and more than 1 in 7 Medicare beneficiaries underwent a major surgery over five years, representing nearly 5 million unique older people. Therefore, these surgeries are expected to require adhesion barriers for the reduction of scars, thereby, the market is expected to see a surge over the forecast period.

Moreover, a growing number of surgical procedures due to sports injuries, accidents, and orthopedic surgeries owing to a high prevalence of orthopedic diseases, and other chronic conditions where the surgery is being suggested as mandatory is the major factor that is driving the adhesion barrier market. The National Safety Council (NSC) facts and figures for injury in United States July 2020 report show that bicycling accounted for about 426,000 injuries, and exercise, with or without equipment, accounted for about 378,000 injuries. The injuries due to an all-terrain vehicle (ATV), moped, and minibike were 230,000, and those due to skateboard, scooter, and hoverboard were 218,00. Therefore, an increasing number of injuries is expected to propel the growth of the adhesion barrier globally.

Healthcare in developing countries is undergoing rapid changes. The growing population in these countries is likely to lead to increased demand for medical devices. The growing burden of diseases and innovative medical treatments contributed to nearly two-thirds of the rise in spending. Spending on healthcare in countries such as China and India is expected to increase during the forecast period. According to a report by the World Economic Forum, it is estimated that one-third of all global health expenditures will be accounted for by emerging economies by 2022. Certain investments in the healthcare sector offer attractive long-term financial benefits. Medical care is one such area in which individuals tend to increase spending as incomes grow.

However, the high cost of surgical procedures coupled with side effects associated with adhesion barriers and stringent regulations resulting in limited technological innovations are expected to restrain the growth of the adhesion barrier market.

The adhesive disease represents a significant cause of morbidity for postoperative patients. Most surgical procedures performed by obstetricians and gynecologists are associated with pelvic adhesions that cause subsequent serious sequelae, including small bowel obstruction, infertility, chronic pelvic pain, and difficulty in postoperative treatment, including complexity during subsequent surgical procedures. Adhesion barriers have proven to reduce adhesion-related complications in abdominal surgery. The use of adhesion barriers in open surgery is cost-effective in preventing adhesion-related problems.

According to World Health Organization (WHO), updates from June 2021, cesarean section use continues to rise globally, accounting for more than 1 in 5 (21%) childbirths. If this trend continues, by 2030, the highest rates are likely to be in Eastern Asia(63%), Latin America and the Caribbean (54%), Western Asia (50%), Northern Africa (48%), Southern Europe (47%) and Australia and New Zealand (45%). Moreover, Several countries are also experiencing a rise in surgical procedures, owing to the rising burden of non-communicable diseases and injuries. For instance, per the Organization for Economic Co-operation and Development (OECD), in 2020, 54,836 laparoscopic cholecystectomy procedures were performed in Denmark, and in Costa Rica, the number of courses was 30,031. Thus, the segment is expected to witness significant growth over the forecast period due to the abovementioned factors.

Furthermore, the company's expansions and new developments in abdominal barriers are expected to boost the market growth. For instance, in February 2020, Baxter completed the acquisition of Seprafilm Adhesion Barrier and its assets from Sanofi in a deal worth USD 350 million. Seprafilm is used as an adjunct to reduce the incidence, extent, and severity of adhesions in pelvic and abdominal surgeries. Thus, the market for general/abdominal Surgery is expected to have a notable growth rate over the forecast period.

The increasing rate of surgery in the region has been well-documented. The growth in United States is driven by technological advancement, elderly patients expecting higher levels of function, and reimbursement models that incentivize complex fusion surgery. Adhesion barriers are also useful in oncology surgeries. Furthermore, growing awareness among the population to approach surgical procedures in case of injuries and chronic disease problems is also driving market growth.

The rising number of surgeries concerning cardiovascular and neurological diseases within the North American region is likely to have a positive impact on the market growth. For instance, according to the Center for Disease Control and Prevention's 2022 update, a total of 18.2 million adults had coronary artery disease, and approximately 70% of these patients underwent surgery. In addition, as per the same source, almost 659,000 Americans die from heart disease each year. Moreover, there are nearly 35 million hospital stays each year in United States. Hence, this rise in hospital stays and surgeries is likely to have a positive impact on the market's growth.

Additionally, the increasing number of accidents and amputations in the country is also expected to drive the market for adhesion barriers in North America. The article titled 'Fingertip injuries and Amputations: A review of the literature ' published in May 2020 mentioned that as many as 45,000 finger amputations are performed in United States per year with an incidence rate of 7.5 per 100,000 people. Such amputations are expected to drive the demand for adhesion barrier in United States. Moreover, according to the National Safety Council (NSC), in July 2021, 5,26,000 injuries were reported due to personal exercise, 5,00,000 players were injured due to basketball, 4,57,000 due to bicycling, and 3,41,000 due to football. NSC also reported that 199,000 swimming injuries were treated in the emergency room. Spine, shoulder, head, and knee injuries accounted for more than 50% of these total injuries.​ Thus, increasing number of injuries that required medical attention is further expected to boosts the market in the region over the forecast period.

Thus, all the aforementioned factors, such as rising in injury cases coupled with the product launch, boost the market in the region.

The adhesion barrier market is moderately competitive and consists of a few major players. Companies like Anika Therapeutics, Baxter International, Leader Biomedical, Betatech Medical, FzioMed, Innocoll Holdings, Integra LifeSciences Holdings Corporation, Johnson & Johnson, MAST Biosurgery, Sanofi, among others, hold a substantial market share in the Adhesion Barrier market.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support